{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:14:51Z","timestamp":1775031291910,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7202220"],"award-info":[{"award-number":["7202220"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10637-023-01394-z","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T07:02:14Z","timestamp":1700204534000},"page":"24-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular profiling and prognostic analysis in Chinese cholangiocarcinoma: an observational, retrospective single-center study"],"prefix":"10.1007","volume":"42","author":[{"given":"Changkun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"1394_CR1","doi-asserted-by":"publisher","unstructured":"Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P et al (2016) ;13(5):261 \u2013 80. https:\/\/doi.org\/10.1038\/nrgastro.2016.51, PMID: 27095655. https:\/\/doi.org\/10.1038\/nrgastro.2016.51","DOI":"10.1038\/nrgastro.2016.51"},{"issue":"9","key":"1394_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","volume":"8","author":"B Blechacz","year":"2011","unstructured":"Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8(9):512\u2013522. https:\/\/doi.org\/10.1038\/nrgastro.2011.131","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"1394_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15(2):95\u2013111. https:\/\/doi.org\/10.1038\/nrclinonc.2017.157","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"1394_CR4","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","volume":"4","author":"C Fitzmaurice","year":"2018","unstructured":"Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C et al (2018) Global, Regional, and National Cancer incidence, mortality, years of Life Lost, Years lived with disability, and disability-adjusted life-years for 29 Cancer groups, 1990 to 2016: a systematic analysis for the global burden of Disease Study. JAMA Oncol 4(11):1553\u20131568. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2706","journal-title":"JAMA Oncol"},{"issue":"6","key":"1394_CR5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"S Rizvi","year":"2013","unstructured":"Rizvi S, Gores GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145(6):1215\u20131229. https:\/\/doi.org\/10.1053\/j.gastro.2013.10.013","journal-title":"Gastroenterology"},{"issue":"2","key":"1394_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/1078-0432.CCR-14-3296","volume":"22","author":"A Moeini","year":"2016","unstructured":"Moeini A, Sia D, Bardeesy N, Mazzaferro V, Llovet JM (2016) Molecular Pathogenesis and targeted therapies for Intrahepatic Cholangiocarcinoma. Clin Cancer Res 22(2):291\u2013300. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-3296","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1394_CR7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M et al (2015) Genomic spectra of biliary tract cancer. Nat Genet 47(9):1003\u20131010. https:\/\/doi.org\/10.1038\/ng.3375","journal-title":"Nat Genet"},{"issue":"8","key":"1394_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/hpb.12441","volume":"17","author":"SM Weber","year":"2015","unstructured":"Weber SM, Ribero D, O\u2019Reilly EM, Kokudo N, Miyazaki M, Pawlik TM (2015) Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17(8):669\u2013680. https:\/\/doi.org\/10.1111\/hpb.12441","journal-title":"HPB (Oxford)"},{"issue":"4","key":"1394_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BSJ et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234(4):507\u2013517 discussion 517-9. https:\/\/doi.org\/10.1097\/00000658-200110000-00010","journal-title":"Ann Surg"},{"issue":"7","key":"1394_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ejso.2007.10.005","volume":"34","author":"E Hidalgo","year":"2008","unstructured":"Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR et al (2008) Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol 34(7):787\u2013794. https:\/\/doi.org\/10.1016\/j.ejso.2007.10.005","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"1394_CR11","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.4143\/crt.2017.320","volume":"50","author":"T Yoo","year":"2018","unstructured":"Yoo T, Park SJ, Han SS, Kim SH, Lee SD, Kim TH et al (2018) Proximal resection margins: more prognostic than distal resection margins in patients undergoing Hilar Cholangiocarcinoma Resection. Cancer Res Treat 50(4):1106\u20131113. https:\/\/doi.org\/10.4143\/crt.2017.320","journal-title":"Cancer Res Treat"},{"issue":"2","key":"1394_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/030089161410000217","volume":"100","author":"MT Huggett","year":"2014","unstructured":"Huggett MT, Passant H, Hurt C, Pereira SP, Bridgewater J, Mukherjee S (2014) Outcome and patterns of care in advanced biliary tract carcinoma (ABC): experience from two tertiary institutions in the United Kingdom. Tumori 100(2):219\u2013224. https:\/\/doi.org\/10.1177\/030089161410000217","journal-title":"Tumori"},{"issue":"12","key":"1394_CR13","doi-asserted-by":"publisher","first-page":"e115383","DOI":"10.1371\/journal.pone.0115383","volume":"9","author":"CR Churi","year":"2014","unstructured":"Churi CR, Shroff R, Wang Y, Rashid A, Kang HC, Weatherly J et al (2014) Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PLoS ONE 9(12):e115383. https:\/\/doi.org\/10.1371\/journal.pone.0115383","journal-title":"PLoS ONE"},{"issue":"4","key":"1394_CR14","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3892\/ol.2020.11429","volume":"19","author":"W Tian","year":"2020","unstructured":"Tian W, Hu W, Shi X, Liu P, Ma X, Zhao W et al (2020) Comprehensive genomic profile of cholangiocarcinomas in China. Oncol Lett 19(4):3101\u20133110. https:\/\/doi.org\/10.3892\/ol.2020.11429","journal-title":"Oncol Lett"},{"issue":"1","key":"1394_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5604\/16652681.1226927","volume":"16","author":"D Waseem","year":"2017","unstructured":"Waseem D, Tushar P (2017) Intrahepatic, perihilar and distal cholangiocarcinoma: management and outcomes. Ann Hepatol 16(1):133\u2013139. https:\/\/doi.org\/10.5604\/16652681.1226927","journal-title":"Ann Hepatol"},{"issue":"6","key":"1394_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR et al (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23(6):703\u2013713. https:\/\/doi.org\/10.1038\/nm.4333","journal-title":"Nat Med"},{"issue":"269","key":"1394_CR17","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"issue":"9","key":"1394_CR18","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M et al (2015) Genomic spectra of biliary tract cancer. Nat Genet 47(9):1003\u20131010. https:\/\/doi.org\/10.1038\/ng.3375","journal-title":"Nat Genet"},{"issue":"10","key":"1394_CR19","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","volume":"7","author":"A Jusakul","year":"2017","unstructured":"Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N et al (2017) Whole-genome and epigenomic landscapes of etiologically distinct subtypes of Cholangiocarcinoma. Cancer Discov 7(10):1116\u20131135. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0368","journal-title":"Cancer Discov"},{"issue":"2","key":"1394_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E et al (2018) Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of Cancer. Cell 173(2):291\u2013304e6. https:\/\/doi.org\/10.1016\/j.cell.2018.03.022","journal-title":"Cell"},{"key":"1394_CR21","doi-asserted-by":"publisher","unstructured":"Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J et al OncoKB: a Precision Oncology Knowledge Base. JCO Precis Oncol 2017;2017:PO.17.00011. https:\/\/doi.org\/10.1200\/PO.17.00011","DOI":"10.1200\/PO.17.00011"},{"issue":"9","key":"1394_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17(9):557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"1394_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.21037\/hbsn.2019.08.05","volume":"8","author":"L Xue","year":"2019","unstructured":"Xue L, Guo C, Zhang K, Jiang H, Pang F, Dou Y et al (2019) Comprehensive molecular profiling of extrahepatic cholangiocarcinoma in chinese population and potential targets for clinical practice. Hepatobiliary Surg Nutr 8(6):615\u2013622. https:\/\/doi.org\/10.21037\/hbsn.2019.08.05","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"17","key":"1394_CR24","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","volume":"24","author":"MA Lowery","year":"2018","unstructured":"Lowery MA, Ptashkin R, Jordan E, Berger MF, Zehir A, Capanu M et al (2018) Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: potential targets for intervention. Clin Cancer Res 24(17):4154\u20134161. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0078","journal-title":"Clin Cancer Res"},{"issue":"43","key":"1394_CR25","doi-asserted-by":"publisher","first-page":"12250","DOI":"10.1073\/pnas.1600067113","volume":"113","author":"RV Guest","year":"2016","unstructured":"Guest RV, Boulter L, Dwyer BJ, Kendall TJ, Man TY, Minnis-Lyons SE et al (2016) Notch3 drives development and progression of cholangiocarcinoma. Proc Natl Acad Sci U S A 113(43):12250\u201312255. https:\/\/doi.org\/10.1073\/pnas.1600067113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1394_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.30816","volume":"71","author":"CJ O\u2019Rourke","year":"2020","unstructured":"O\u2019Rourke CJ, Matter MS, Nepal C, Caetano-Oliveira R, Ton PT, Factor VM et al (2020) Identification of a pan-gamma-secretase inhibitor response signature for Notch-Driven Cholangiocarcinoma. Hepatology 71(1):196\u2013213. https:\/\/doi.org\/10.1002\/hep.30816","journal-title":"Hepatology"},{"issue":"1","key":"1394_CR27","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1038\/s41467-022-30708-7","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Ma Z, Li C, Wang C, Jiang W, Chang J et al (2022) The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers. Nat Commun 13(1):3061. https:\/\/doi.org\/10.1038\/s41467-022-30708-7","journal-title":"Nat Commun"},{"key":"1394_CR28","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/ncomms7120","volume":"6","author":"A Fujimoto","year":"2015","unstructured":"Fujimoto A, Furuta M, Shiraishi Y, Gotoh K, Kawakami Y, Arihiro K et al (2015) Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. Nat Commun 6:6120. https:\/\/doi.org\/10.1038\/ncomms7120","journal-title":"Nat Commun"},{"issue":"1","key":"1394_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","volume":"32","author":"J Chaisaingmongkol","year":"2017","unstructured":"Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM et al (2017) Common molecular subtypes among asian Hepatocellular Carcinoma and Cholangiocarcinoma. Cancer Cell 32(1):57\u201370e3. https:\/\/doi.org\/10.1016\/j.ccell.2017.05.009","journal-title":"Cancer Cell"},{"issue":"4","key":"1394_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10147-020-01846-z","volume":"26","author":"F Feng","year":"2021","unstructured":"Feng F, Wu X, Shi X, Gao Q, Wu Y, Yu Y et al (2021) Comprehensive analysis of genomic alterations of chinese hilar cholangiocarcinoma patients. Int J Clin Oncol 26(4):717\u2013727. https:\/\/doi.org\/10.1007\/s10147-020-01846-z","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"1394_CR31","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.21873\/invivo.12816","volume":"36","author":"R Khamko","year":"2022","unstructured":"Khamko R, Wasenang W, Daduang J, Settasatian C, Limpaiboon T (2022) Combined OPCML and AXL expression as a prognostic marker and OPCML enhances AXL inhibitor in Cholangiocarcinoma. In Vivo 36(3):1168\u20131177. https:\/\/doi.org\/10.21873\/invivo.12816","journal-title":"In Vivo"},{"issue":"1","key":"1394_CR32","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1038\/s41598-022-09078-z","volume":"12","author":"M Nyakas","year":"2022","unstructured":"Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN et al (2022) AXL inhibition improves BRAF-targeted treatment in melanoma. Sci Rep 12(1):5076. https:\/\/doi.org\/10.1038\/s41598-022-09078-z","journal-title":"Sci Rep"},{"key":"1394_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2147\/OTT.S150952","volume":"11","author":"S Zhang","year":"2018","unstructured":"Zhang S, Xu XS, Yang JX, Guo JH, Chao TF, Tong Y (2018) The prognostic role of Gas6\/Axl axis in solid malignancies: a meta-analysis and literature review. Onco Targets Ther 11:509\u2013519. https:\/\/doi.org\/10.2147\/OTT.S150952","journal-title":"Onco Targets Ther"},{"issue":"16","key":"1394_CR34","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.3760\/cma.j.issn.0366-6999.20121235","volume":"126","author":"XQ Yan","year":"2013","unstructured":"Yan XQ, Zhang W, Zhang BX, Liang HF, Zhang WG, Chen XP (2013) Inactivation of Smad4 is a prognostic factor in intrahepatic cholangiocarcinoma. Chin Med J (Engl) 126(16):3039\u20133043. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.20121235","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"1394_CR35","doi-asserted-by":"publisher","first-page":"300060522110208","DOI":"10.1177\/03000605221102080","volume":"50","author":"H Song","year":"2022","unstructured":"Song H, Huang Y, Jiang X (2022) Mutation spectrum associated with metastasis of advanced cholangiocarcinoma. J Int Med Res 50(6):3000605221102080. https:\/\/doi.org\/10.1177\/03000605221102080","journal-title":"J Int Med Res"},{"issue":"3","key":"1394_CR36","doi-asserted-by":"publisher","first-page":"e0265655","DOI":"10.1371\/journal.pone.0265655","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu X, Li A, Tang X (2022) A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli. PLoS ONE 17(3):e0265655. https:\/\/doi.org\/10.1371\/journal.pone.0265655","journal-title":"PLoS ONE"},{"key":"1394_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biochi.2018.11.003","volume":"157","author":"AS Aghabozorgi","year":"2019","unstructured":"Aghabozorgi AS, Bahreyni A, Soleimani A, Bahrami A, Khazaei M, Ferns GA et al (2019) Role of adenomatous polyposis coli (APC) gene mutations in the pathogenesis of colorectal cancer; current status and perspectives. Biochimie 157:64\u201371. https:\/\/doi.org\/10.1016\/j.biochi.2018.11.003","journal-title":"Biochimie"},{"issue":"1","key":"1394_CR38","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1038\/s41467-021-23501-5","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang W, Shao F, Yang X, Wang J, Zhu R, Yang Y et al (2021) METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding. Nat Commun 12(1):3803. https:\/\/doi.org\/10.1038\/s41467-021-23501-5","journal-title":"Nat Commun"},{"issue":"8","key":"1394_CR39","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/00042737-200308000-00012","volume":"15","author":"E Koch","year":"2003","unstructured":"Koch E, Fiedler W, Tannapfel A, Ballhausen WG (2003) Alteration of the fragile histidine triad gene in intrahepatic cholangiocarcinoma. Eur J Gastroenterol Hepatol 15(8):907\u2013913. https:\/\/doi.org\/10.1097\/00042737-200308000-00012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"1394_CR40","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1038\/s41467-022-32680-8","volume":"13","author":"N Gulve","year":"2022","unstructured":"Gulve N, Su C, Deng Z, Soldan SS, Vladimirova O, Wickramasinghe J et al (2022) DAXX-ATRX regulation of p53 chromatin binding and DNA damage response. Nat Commun 13(1):5033. https:\/\/doi.org\/10.1038\/s41467-022-32680-8","journal-title":"Nat Commun"},{"issue":"1","key":"1394_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13048-018-0462-4","volume":"11","author":"SB Liu","year":"2018","unstructured":"Liu SB, Lin XP, Xu Y, Shen ZF, Pan WW (2018) DAXX promotes ovarian cancer ascites cell proliferation and migration by activating the ERK signaling pathway. J Ovarian Res 11(1):90. https:\/\/doi.org\/10.1186\/s13048-018-0462-4","journal-title":"J Ovarian Res"},{"issue":"25","key":"1394_CR42","doi-asserted-by":"publisher","first-page":"15406","DOI":"10.1074\/jbc.M115.658765","volume":"290","author":"LA Puto","year":"2015","unstructured":"Puto LA, Brognard J, Hunter T, Transcriptional Repressor DAXX (2015) Promotes prostate Cancer tumorigenicity via suppression of Autophagy. J Biol Chem 290(25):15406\u201315420. https:\/\/doi.org\/10.1074\/jbc.M115.658765","journal-title":"J Biol Chem"},{"issue":"10","key":"1394_CR43","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41416-020-0800-3","volume":"122","author":"C Wu","year":"2020","unstructured":"Wu C, Ding H, Wang S, Li Y, Liu SB, Wang X et al (2020) DAXX inhibits cancer stemness and epithelial-mesenchymal transition in gastric cancer. Br J Cancer 122(10):1477\u20131485. https:\/\/doi.org\/10.1038\/s41416-020-0800-3","journal-title":"Br J Cancer"},{"key":"1394_CR44","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fonc.2019.00420","volume":"9","author":"NW Engel","year":"2019","unstructured":"Engel NW, Schliffke S, Sch\u00fcller U, Frenzel C, Bokemeyer C, Kubisch C et al (2019) Fatal myelotoxicity following palliative Chemotherapy with Cisplatin and Gemcitabine in a patient with stage IV Cholangiocarcinoma Linked to Post Mortem diagnosis of Fanconi Anemia. Front Oncol 9:420. https:\/\/doi.org\/10.3389\/fonc.2019.00420","journal-title":"Front Oncol"},{"issue":"2","key":"1394_CR45","doi-asserted-by":"publisher","first-page":"e31733","DOI":"10.1371\/journal.pone.0031733","volume":"7","author":"JD Roll","year":"2012","unstructured":"Roll JD, Reuther GW (2012) ALK-activating homologous mutations in LTK induce cellular transformation. PLoS ONE 7(2):e31733. https:\/\/doi.org\/10.1371\/journal.pone.0031733","journal-title":"PLoS ONE"},{"issue":"7","key":"1394_CR46","doi-asserted-by":"publisher","first-page":"e102289","DOI":"10.1371\/journal.pone.0102289","volume":"9","author":"JM Pavese","year":"2014","unstructured":"Pavese JM, Ogden IM, Voll EA, Huang X, Xu L, Jovanovic B et al (2014) Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. PLoS ONE 9(7):e102289. https:\/\/doi.org\/10.1371\/journal.pone.0102289","journal-title":"PLoS ONE"},{"issue":"22","key":"1394_CR47","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.18632\/aging.102485","volume":"11","author":"S Liu","year":"2019","unstructured":"Liu S, Huang J, Zhang Y, Liu Y, Zuo S, Li R (2019) MAP2K4 interacts with vimentin to activate the PI3K\/AKT pathway and promotes breast cancer pathogenesis. Aging 11(22):10697\u201310710. https:\/\/doi.org\/10.18632\/aging.102485","journal-title":"Aging"},{"issue":"21","key":"1394_CR48","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1128\/MCB.05562-11","volume":"31","author":"YH Ahn","year":"2011","unstructured":"Ahn YH, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II et al (2011) Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor \u03b32 expression. Mol Cell Biol 31(21):4270\u20134285. https:\/\/doi.org\/10.1128\/MCB.05562-11","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1394_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY et al (2019) Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet 51(2):202\u2013206. https:\/\/doi.org\/10.1038\/s41588-018-0312-8","journal-title":"Nat Genet"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-023-01394-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-023-01394-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-023-01394-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T10:07:23Z","timestamp":1708682843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-023-01394-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1007\/s10637-023-01394-z","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of Peking University People\u2019s Hospital (2021PHB279-001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived given the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no conflict of interests related to this publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}